HR (95% CI) | P | |
---|---|---|
MPGN | 0.61 (0.29–1.26) | 0.18 |
Age | 1.08 (1.04–1.12) | < 0.01 |
Male | 0.80 (0.38–1.70) | 0.57 |
Ethnicity | ||
Caucasian | Ref | 0.11 |
ATSI | 18.36 (3.22–104.72) | |
MPI | 2.54 (0.70–9.16) | |
sian | 0.88 (0.11–6.82) | |
Other | 1.09 (0.01–10.3) | |
Hepatitis C Antibody Positive | 5.97 (1.47–24.24) | 0.01 |
Current Smoker | 0.96 (0.34–2.76) | 0.94 |
Diabetes Mellitus | 0.47 (0.11–2.05) | 0.31 |
Coronary Artery Disease | 2.48 (0.89–6.90) | 0.08 |
Peripheral Vascular Disease | 0.83 (0.10–7.11) | 0.87 |
Cerebrovascular Disease | 2.00 (0.26–15.13) | 0.50 |
Previous Diagnosis of Cancer | 3.46 (1.06–11.25) | 0.04 |
Chronic Lung Disease | 3.79 (1.17–12.27) | 0.03 |
First KRT modality | ||
HD | Ref | 0.09 |
PD | 0.78 (0.31–1.98) | |
Pre-emptive transplant | 0.13 (0.02–1.07) | |
Late referral to dialysis | 0.21 (0.05–0.97) | 0.05 |
Transplant era 2007–16 | 1.97 (0.83–4.66) | 0.12 |